Institut Pasteur Filing Patent on SARS-COV-2

(To join our email list, click here.)
Breaking News

Two thousand eleven saw the Institut Pasteur filing a further patent application for “SARS-COV-2,” which was identical to the previous one, … because commercial exploitation of the first patent started in 2003 and would expire 20 years later, in 2023. According to Fourtillan, four sequences of the HIV virus — responsible for AIDS — were added to the virus, in view of creating further vaccines.

© 2007-2021 Walk In Verse All rights reserved

Share This

Share on facebook
Share on twitter
Share on telegram
Share on tumblr

Get News & Updates

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top